| COMVX | RYVTX | COMVX / RYVTX | |
| Total Expense Ratio | 0.00 | 1.90 | - |
| Annual Report Gross Expense Ratio | 3.15 | 1.99 | 158% |
| Fund Existence | 18 years | 22 years | - |
| Gain YTD | 3.386 | -22.231 | -15% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | 250 | 1000 | 25% |
| Net Assets | 11M | 11.3M | 97% |
| Annual Yield % from dividends | 1.89 | 15.77 | 12% |
| Returns for 1 year | 6.61 | -33.58 | -20% |
| Returns for 3 years | 25.32 | -73.69 | -34% |
| Returns for 5 years | 32.15 | -82.57 | -39% |
| Returns for 10 years | -29.61 | -99.21 | 30% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SLVAX | 44.68 | 0.29 | +0.65% |
| Columbia Select Large Cap Value A | |||
| HFDSX | 22.00 | 0.06 | +0.27% |
| Hartford Schroders US MidCap Opps R4 | |||
| RRMGX | 85.37 | -0.15 | -0.18% |
| T. Rowe Price Mid-Cap Growth R | |||
| JMNCX | 12.29 | -0.03 | -0.24% |
| JPMorgan Research Market Neutral C | |||
| MEMLX | 15.55 | -0.29 | -1.83% |
| Morgan Stanley Inst EMkts Ldrs C | |||